Are you Dr. Kinast?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 46 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1040 Nw 22nd Ave
Suite 200
Portland, OR 97210Phone+1 503-413-8202
Summary
- Dr. Robert Kinast, MD is a board certified ophthalmologist in Portland, Oregon. He is currently licensed to practice medicine in Oregon, California, and Pennsylvania. He is affiliated with Legacy Good Samaritan Medical Center and Providence St. Vincent Medical Center.
Education & Training
California Pacific Medical CenterResidency, Ophthalmology, 2007 - 2010
Presbyterian Medical Center of the University of Pennsylvania Health SystemInternship, Transitional Year, 2006 - 2007
University of Michigan Medical SchoolClass of 2006
Certifications & Licensure
CA State Medical License 2007 - Present
OR State Medical License 2010 - 2025
PA State Medical License 2006 - 2007- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- A Universal Eye Drop Adherence Monitor to Measure and Improve Adherence to Ocular Medications Start of enrollment: 2020 Oct 02
Publications & Presentations
PubMed
- Eye Drop Adherence With an Eye Drop Bottle Cap Monitor.Robert M Kinast, Facundo G Sanchez, Jack P Rees, Kaileen Yeh, Stuart K Gardiner
Journal of Glaucoma. 2023-05-01 - Patients with Low Vision Struggle with Placing Eye Drops and Benefit from an Eye Drop Aid.Nick Grissom, Stuart K Gardiner, Jack P Rees, Facundo G Sanchez, Steven L Mansberger
Ophthalmology. Glaucoma. 2023-04-20 - Optic nerve cavitations in glaucoma suspect and glaucoma patients.Bennett Y Hong, Brad Fortune, Robert M Kinast, Claude F Burgoyne, Jack P Rees
American Journal of Ophthalmology Case Reports. 2022-12-01
Press Mentions
Drug Delivery: Real-World Updates and Future OutlookJune 28th, 2022
